Comparison between Bizotic Commercial IPO and Vilin Bio Med IPO.
Bizotic Commercial IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vilin Bio Med IPO is a SME Fixed Price proposed to list at NSE SME.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bizotic Commercial IPO is up to ₹40.10 Cr whereas the issue size of the Vilin Bio Med IPO is up to ₹11.38 Cr. The final issue price of Bizotic Commercial IPO is ₹175.00 per share and of Vilin Bio Med IPO is ₹30.00 per share.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹175.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 800 shares | 4000 shares |
| Fresh Issue Size | 22,91,200 shares | 37,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹40.10 Cr | up to ₹11.38 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 22,91,200 shares | 37,92,000 shares |
| Issue Size Total (Amount) | up to ₹40.10 Cr | up to ₹11.38 Cr |
Bizotic Commercial IPO opens on Jun 12, 2023, while Vilin Bio Med IPO opens on Jun 16, 2023. The closing date of Bizotic Commercial IPO and Vilin Bio Med IPO is Jun 15, 2023, and Jun 21, 2023, respectively.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 12, 2023 | Jun 16, 2023 |
| Issue Close | Jun 15, 2023 | Jun 21, 2023 |
| Basis Of Allotment (Tentative) | Jun 20, 2023 | Jun 26, 2023 |
| Initiation of Refunds (Tentative) | Jun 21, 2023 | Jun 27, 2023 |
| Credit of Share (Tentative) | Jun 22, 2023 | Jun 29, 2023 |
| Listing date (Tentative) | Jun 23, 2023 | Jun 30, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bizotic Commercial IPO P/E ratio is 36.38, as compared to Vilin Bio Med IPO P/E ratio of 24.59.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 91.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 36.38 | 24.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹140.70 Cr. | ₹41.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.76% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 8.58% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.71 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.82 | ₹0.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 51.27% | 1.15% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bizotic Commercial IPO Retail Individual Investors (RII) are offered 11,45,600 shares while in Vilin Bio Med IPO retail investors are offered 11,45,600 shares. Qualified Institutional Buyers (QIB) are offered in Bizotic Commercial IPO and in Vilin Bio Med IPO.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,20,800 shares | 2,08,000 shares |
| QIB | ||
| NII | 11,45,600 shares | 18,96,000 shares |
| RII | 11,45,600 shares | 18,96,000 shares |
| Employee | ||
| Others | ||
| Total | 22,91,200 shares | 37,92,000 shares |
Bizotic Commercial IPO subscribed 1.87x in total, whereas Vilin Bio Med IPO subscribed 2.80x.
| Bizotic Commercial IPO | Vilin Bio Med IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.00x | 1.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.74x | 4.31x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.87x | 2.80x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
